MISSED OPPORTUNITIES IN THE MONITORING OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS)

被引：0
|
作者：
Dyaanand, H. [1 ]
Dickson, M. [1 ]
Tilley, D. [1 ]
Nisar, M. [1 ]
机构：
[1] Queens Hosp, Dept Rheumatol, Burton Upon Trent, England
来源：
RHEUMATOLOGY | 2002年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] Monitoring of disease modifying anti-rheumatic drugs (DMARDs) - potential pitfalls of combination therapy
    Bhattacharyya, S.
    Gamon, S.
    Vail, A.
    Herrick, A. L.
    RHEUMATOLOGY, 2001, 40 : 37 - 37
  • [2] Cardiovascular Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
    Drakopoulou, Maria
    Soulaidopoulos, Stergios
    Oikonomou, George
    Tousoulis, Dimitrios
    Toutouzas, Konstantinos
    CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (05) : 488 - 506
  • [3] AUTOMATING BLOOD MONITORING AND HANDOVER FOR PATIENTS WITH RHEUMATIC DISEASES COMMENCING DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS)
    Mirza, Maria
    Lang, David
    Escudero, Alexa
    Soni, Anushka
    Shine, Brian
    Paddon, Kevin
    Luqmani, Raashid
    RHEUMATOLOGY, 2023, 62
  • [4] DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    STECHER, VJ
    CARLSON, JA
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 1983, 18 : 171 - 179
  • [5] The use of disease modifying anti-rheumatic drugs (DMARDs) in pregnancy; When evidence is scarce
    Vroom, Fokaline
    van Roon, Eric N.
    van den Berg, Paul B.
    Brouwers, Jacobus R. B. J.
    de Jong-van den Berg, Lolkje T. W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S165 - S166
  • [6] Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience
    D.C. Nordström
    L. Konttinen
    M. Korpela
    T. Tiippana-Kinnunen
    K. Eklund
    S. Forsberg
    K. Ilva
    O. Kaipiainen-Seppänen
    T. Malmi
    T. Ylä-Kerttula
    V. Honkanen
    Rheumatology International, 2006, 26 : 741 - 748
  • [7] A call for guidance on the treatment of patients taking disease-modifying anti-rheumatic drugs (DMARDs)
    Dickson, Kirsty Skye
    Regan, Alasdair
    Wemyss, Callum
    Paley, Martin
    Siddiqui, Arshad
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2024, 62 (04): : 389 - 390
  • [8] Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab.: The Finnish experience
    Nordström, C
    Konttinen, L
    Korpela, M
    Tiippana-Kinnunen, T
    Eklund, K
    Forsberg, S
    Ilva, K
    Kaipiainen-Seppänen, O
    Malmi, T
    Ylä-Kerttula, T
    Honkanen, V
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (08) : 741 - 748
  • [9] Facing ineffectiveness of disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA): Shall DMARDs be switched or be combined?
    Schoels, M
    Kapral, T
    Stamm, T
    Smolen, JS
    Aletaha, D
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S545 - S545
  • [10] Pharmacogenetics of disease-modifying anti-rheumatic drugs
    Tanaka, E
    Taniguchi, A
    Urano, W
    Yamanaka, H
    Kamatani, N
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (02): : 233 - 247
12345